| Tag | Content |
|---|
EnhancerAtlas ID | HS109-23759 |
Organism | Homo sapiens |
Tissue/cell | Kasumi-1 |
Coordinate | chrX:1600420-1601430 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| MEOX1 | MA0661.1 | chrX:1601158-1601168 | GCTAATTAAC | + | 6.02 |
|
| | Number of super-enhancer constituents: 9 | ID | Coordinate | Tissue/cell |
| SE_09748 | chrX:1599661-1601729 | CD14 | | SE_10317 | chrX:1600012-1601515 | CD19_Primary | | SE_11269 | chrX:1597450-1603818 | CD20 | | SE_12201 | chrX:1598342-1601632 | CD3 | | SE_16610 | chrX:1599473-1601769 | CD4_Naive_Primary_8pool | | SE_18552 | chrX:1598078-1603697 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_20171 | chrX:1597547-1601775 | CD56 | | SE_22596 | chrX:1596285-1601637 | CD8_primiary | | SE_32559 | chrX:1598504-1601682 | GM12878 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH0XI001480 | chrX | 1599695 | 1601493 |
|
Enhancer Sequence | AGCTTTGGGT TTAAGGAGCC CAGCTTTGGG TTTAGGAGAG TCCAGCTTTG GGATTAGGAG 60
AGTCCAGCTT TGGGATTAGG AGAGTCCAGC TTTGGGATTA GGAGAGTCCA GCTTTGGGTT 120
TAGTGGAGCT CAGCTTCCAA CCCTCGCACC CTCAAAGTTC CCCATCTTTG TAGACCCAGT 180
GACCCCTGTT TCTGTGATAA CACCTGCCTC TGAACGAACT CTGTGTTCTA CTGACTTCAA 240
AGTGACCCAC CAGCCCCAGT GAACTGGCAG CTGGCAGGCG TCAGGGGATA GAGGACCTGC 300
TGGCGTCGGC CTCAGATCAC AAGGCAAGAA TCCTCCTAGC TAAGCACAAA AACGCGTAGG 360
AAATGCTCTG AGCTCTGCCG CTGTGTGTTG ATTTTCCTGT ATTGCATCAC CCAACGAAGC 420
AGACCGTTTG CCCAGCGAGA TTTGCATGCT GTCCTCCGCA GACGCCCCGT GGAGATTTTG 480
ATCTGCGTCT TCTGCAAAGG CAGCGGCCGC GTTTCTCTGA TTTCTGTATC TCATTCTCAG 540
AGTATATAGC ACGGGGCTTC ATCGCTGGCC AGAGAGCAGA TTCTGAGAAA CATAAGAAGC 600
CCCTTTTTGA AACAAAATTA ATTTGTGTGT GTGGTGTGTG TGTGTGTGTG TGTGTGTGTG 660
TGTATGGGTG AGGATGTCTC AACAGCAGCA AAATCGGCCT CACTCTGGAA GGCAGGAAGC 720
CACTGTACGT GGAATTAAGC TAATTAACAT GAAATGCCAT TTGGTGAAAA AAAAAAAAAA 780
AACCCAAAGT GGTTGAGTGT GTGGCTCCTG CCCTGCTGCA AAAGAAGAGT GTGGAAATAG 840
CACGTATGCT GAAATTTAAG CACTTCTGCC GTTACTGAGC CACAGTGCCC ATGGTTTTAG 900
CAGGTTATGG CAGACAGATT CATTTAACAG ATGAGAGAGA GGTGACAGGA AGGTTCGCAG 960
GCTTGACTTC CTAACAGCTG CTCTCTGTTT AAAGATCGTT GCTCTAGACA 1010
|
